Slamming Cancer: A Conversation with Steve Potts, CEO of SLAM BioTherapeutics

10:08 | Jun 18th, 2024

Commons host, Thomas Osha, catches up with serial entrepreneur, Steve Potts, to discuss his latest venture, SLAM BioTherapeutics. Slam Bio is developing a platform of first-in-class monoclonal antibo...Show More